Hypertrophic cardiomyopathy

There are 91 papers on hypertrophic cardiomyopathy in aging research: 47 observational studies in people, 13 in animals, 2 in cells, 22 reviews. The newest story, Nov 9, 2026: “Heart tracing model better flags high levels of heart scarring”.

Disease

91 papers study it22 more mention it15 findings

39 new papers in 30 daysSee all 113 papers on hypertrophic cardiomyopathy

At a glance

Human studies show that a deep-learning echocardiographic model and a polygenic risk score predict hypertrophic cardiomyopathy. A human preprint reports prediction by an AI-ECG score in sarcomere variant carriers and greater disease risk among UK Biobank participants with both high AI-ECG and polygenic risk scores.

15 findings in 13 papers from 2017 to 2026, 7 of them since September 2026

“A new PRS was significantly associated with HCM diagnosis (HR=3.19, 95% CI 2.46 to 4.14 for top 5% vs lower 95%; HR=1.88, 95% CI 1.72 to 2.06 per SD increase).”
Hypertrophic cardiomyopathy: a genome-wide association meta-analysis and polygenic risk scoreJournal of medical genetics2026doi:10.1136/jmg-2026-111722
  • Humans47
  • Animals12
  • Model organisms1
  • Cells2
  • In silico6

Effects

3

Extracellular matrix remodeling

upin humans1

1 study
  1. Hypertrophic cardiomyopathy is linked with higher extracellular matrix remodeling in humans across adult HCM age groups (498 shared DEGs).

    “Shared DEGs exhibited an extracellular matrix (ECM)-related functional profile and formed PPI modules associated with ECM homeostasis and immune regulation.”

    Humansacross adult HCM age groupsleft ventricle

    Age-Stratified Integrative Transcriptomic Analysis Reveals a Conserved Fibrotic Core and Distinct Molecular Signatures in Hypertrophic Cardiomyopathy

    Cardiogenetics

More on Extracellular matrix remodeling

Cardiomyocyte function markers

upin F. catus1

1 study
  1. Hypertrophic cardiomyopathy increases cardiomyocyte function markers in F. catus (feline HCM).

    “comparison between the older adult control cats and those with HCM showed increased transcription levels for most markers associated with the disease”

    Animalsfeline HCMmyocardium

    Selected Pathway Analyses to Gain Mechanistic Insights into the Pathogenesis of Feline Hypertrophic Cardiomyopathy

    International journal of molecular sciences

More on Cardiomyocyte function markers

LC3-II

upin humans1

1 study
  1. Hypertrophic cardiomyopathy is linked with higher LC3-II in humans (patients with MYBPC3 mutations, septal myectomies versus nonfailing control hearts).

    “Microtubule-associated protein 1 light chain 3 (LC3)-II protein levels were higher in HCM septal myectomies than in nonfailing control hearts”

    Humanspatients with MYBPC3 mutations, septal myectomies versus nonfailing control heartsheart

    Activation of Autophagy Ameliorates Cardiomyopathy in Mybpc3-Targeted Knockin Mice

    Circulation. Heart failure

More on LC3-II

Upstream

1

Time

upin humans1+80%

1 study
  1. time is linked with higher hypertrophic cardiomyopathy in humans (+80%).

    “The age-adjusted incidence of HCM increased 80% over time, while DCM and RCM remained stable.”

    Humans

    Lifetime risk of heart muscle disease was 2.5% in Sweden

    ESC Congress 2026 abstract

Associations

9

Frontal QRS-T angle

upin humans1

1 study
  1. Frontal QRS-T angle is associated with hypertrophic cardiomyopathy in humans (Multivariate logistic regression) (Adjusted OR per 1° increase 1.023; 95% CI 1.008-1.039; p = 0.003).

    “frontal QRS-T angle was independently associated with HCM (adjusted OR per 1° increase 1.023; 95% CI 1.008-1.039; p = 0.003).”

    HumansMultivariate logistic regressionper 1° increase

    Screening for hypertrophic cardiomyopathy in adults using ECG-derived frontal QRS-T angle

    Journal of electrocardiology

  2. Frontal QRS-T angle predicts hypertrophic cardiomyopathy in humans (AUC 0.711 (95% CI 0.520-0.901); sensitivity 67% and specificity 86% at 44.5°).

    “the frontal QRS-T angle demonstrated fair discriminatory ability for HCM detection, with an area under the ROC curve (AUC) of 0.711 (95% CI 0.520-0.901).”

    HumansPrimary definition: septal or posterior left ventricular wall thickness ≥15 mm in the absence of hypertensionn = 3,133

    Screening for hypertrophic cardiomyopathy in adults using ECG-derived frontal QRS-T angle

    Journal of electrocardiology

More on Frontal QRS-T angle

AI-ECG HCM score

upin humans1

1 study
  1. AI-ECG HCM score is linked with a higher risk of hypertrophic cardiomyopathy in humans (UK Biobank participants with high AI-ECG and high PRS) (adjusted OR 60.2, 95% CI 26.5-137.2).

    “individuals with both high AI-ECG and high PRS had 60-fold higher odds of HCM (adjusted OR 60.2; 95% CI 26.5-137.2)”

    HumansUK Biobank participants with high AI-ECG and high PRSn = 57,007

    AI-based ECG detects and predicts hypertrophic cardiomyopathy

    medRxiv : the preprint server for health sciencesPreprint

  2. AI-ECG HCM score predicts hypertrophic cardiomyopathy in humans (sarcomere variant carriers) (AUROC 0.91, 95% CI 0.89-0.93).

    “AI-ECG achieved an AUROC of 0.91 (95% CI 0.89-0.93) for P+ at baseline”

    Humanssarcomere variant carriers52.1% femalesn = 1,095

    AI-based ECG detects and predicts hypertrophic cardiomyopathy

    medRxiv : the preprint server for health sciencesPreprint

More on AI-ECG HCM score

PGS004911

upin humans1OR 1.73

1 study
  1. PGS004911 is associated with hypertrophic cardiomyopathy in humans (European ancestry; Phenotype A; 562 cases) (OR 1.73 per SD, 95% CI 1.59–1.87).

    “the HCM PGS was associated with HCM in European (EUR; 562 cases, OR 1.73 per SD, 95% CI 1.59-1.87)”

    HumansEuropean ancestry; Phenotype A; 562 cases

    Validation and Cross-Ancestry Evaluation of Hypertrophic Cardiomyopathy Polygenic Score in a Diverse Population-Based Cohort

    AHA Scientific Sessions 2026 abstract

More on PGS004911

Deep-learning echocardiographic model

upin humans1

1 study
  1. deep-learning echocardiographic model predicts hypertrophic cardiomyopathy in humans (independent test cohort) (AUC 0.982 (95% CI 0.966-0.993)).

    “The model achieved excellent discrimination with an area under the curve of 0.982 (95% CI 0.966-0.993)”

    Humansindependent test cohortn = 12,096

    Point-of-care echocardiography screening for hypertrophic cardiomyopathy using automated deep-learning analysis

    European heart journal. Digital health

Polygenic risk score

upin humans1HR 3.19

1 study
  1. Polygenic risk score predicts hypertrophic cardiomyopathy in humans (top 5% vs lower 95%) (HR=3.19, 95% CI 2.46 to 4.14).

    “A new PRS was significantly associated with HCM diagnosis (HR=3.19, 95% CI 2.46 to 4.14 for top 5% vs lower 95%; HR=1.88, 95% CI 1.72 to 2.06 per SD increase).”

    Humanstop 5% vs lower 95%n = 411,213

    DNA study finds new links to inherited heart muscle disease

    Journal of medical genetics

More on Polygenic risk score

Sudden cardiac death

upin humans1

1 study
  1. Hypertrophic cardiomyopathy is associated with sudden cardiac death in humans (amateur athletes) (Most frequently reported cause).

    “The most frequently reported cause of SCD in amateur athletes was hypertrophic cardiomyopathy”

    Reviewamateur athletes

    Cardiovascular diseases and risk factors associated with sudden cardiac death in amateur athletes: a scoping review

    Frontiers in public health

More on Sudden cardiac death

Cardiac lectin-binding profiles

mixedin F. catus1

1 study
  1. Hypertrophic cardiomyopathy is associated with cardiac lectin-binding profiles in F. catus.

    “The observed shifts in lectin-binding profiles reveal specific remodelling associated with aging and HCM in cats.”

    Animalsmyocardiumn = 64

    Glyco-Architectural Remodelling of the Feline Heart: Age- and HCM-Related Insights from Lectin Histochemistry

    Life (Basel, Switzerland)

More on Cardiac lectin-binding profiles

Noise-adapted AI-ECG model

upin silico1

1 study
  1. Noise-adapted AI-ECG model predicts hypertrophic cardiomyopathy in silico (internal validation held-out test) (AUROC 0.95 (95% CI 0.93-0.97)).

    “The model demonstrated robust discrimination in internal validation with an area under the receiver operating curve (AUROC) of 0.95 (95% CI 0.93-0.97), sensitivity of 0.90 and specificity op 0.90”

    In silicointernal validation held-out testn = 38,426

    Artificial Intelligence-based screening for Hypertrophic Cardiomyopathy from Single-lead Electrocardiograms: A Multinational Development and Validation Study

    AHA Scientific Sessions 2025 abstract

More on Noise-adapted AI-ECG model

Metformin

downin humans1OR 0.01

1 study
  1. Metformin is linked with a lower risk of hypertrophic cardiomyopathy in humans (OR = 0.01, 95% CI 0.00-0.22).

    “and hypertrophic cardiomyopathy (OR = 0.01, 95% CI 0.00-0.22; P = 0.016).”

    Humans

    Causal association of metformin treatment with diverse cardiovascular diseases: a Mendelian randomization analysis

    Aging

More on Metformin

Trial sponsors

Funding

7 grants since 2016

National Heart, Lung, and Blood Institute$2.9MNational Center for Advancing Translational Sciences$2MAmerican Heart Association$154K

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 3Jan 2026: 2Feb 2026: 6Mar 2026: 9Apr 2026: 2May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 9Oct 2026: 19Nov 2026: 2070 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Heart tracing model better flags high levels of heart scarring

It scored 0.674 versus 0.597 for a clinical model on a measure of how well it distinguished people with high heart muscle scarring.It scored 0.674 versus 0.597 for a clinical model on a measure of how well it distinguished people with high heart muscle scarring.

Cohort · 8,048 peopleBiomarkers

See all 113 papers on hypertrophic cardiomyopathy